Examining state & federal oversight to ensure the safety & quality of drug compounding -- the process of mixing, combining, or altering ingredients to create a customized medication for an individual patient -- by pharmacies. Witnesses: Janet Heinrich, DrPH, RN, Dir. of Health Care-Public Health Issues, Gen. Accounting Office (GAO); Steven Galson, M.D., MPH, Deputy Dir., Center for Drug Evaluation & Research, U.S. Food & Drug Admin. (FDA); Sarah L. Sellers, PHARM.D, Exec. Dir., The Center for Pharmaceutical Safety; Daniel A. Herbert, RPh, Pres. Elect, Amer. Pharmacists Assoc.; Kevin Kindake, Exec. Dir., Missouri Board of Pharmacy; & William Kennedy, owner, Nephron Pharmaceuticals Corp.Bond, Christopher S. is the author of 'Federal And State Role In Pharmacy Compounding And Reconstitution Exploring The Right Mix To Protect Patients Hearing Before The Committee On Health, Education, Labor, And Pensions, U.s. Senate', published 2004 under ISBN 9780756741570 and ISBN 0756741572.